A Phase I study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898

Trial Identifier:	D7620C00001
Sponsor:	AstraZeneca
Collaborator:	PAREXEL
NCTID::	NCT03140072
Start Date:	May 2017
Primary Completion Date:	August 2017
Study Completion Date:	August 2017
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Harrow, United Kingdom, HA1 3UJ
United Kingdom	Manchester, United Kingdom, M23 9QZ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.